Montsouris Institute, Paris Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2011
NCT01442246
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now